FDA Inspection 965285 — Medtronic Heart Valves Division

Medtronic Heart Valves Division — FEI 2025587

The FDA completed an inspection of Medtronic Heart Valves Division on March 30, 2016 in Santa Ana, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 30, 2016
Fiscal Year
2016
Product Type
Devices
Project Area
Compliance: Devices
Location
Santa Ana, CA (United States)

Citations

IDCFRDescription
317221 CFR 820.198(c)Investigation of device failures
368021 CFR 820.70(a)Process control procedures, Lack of or inadequate procedures